Brief: Aeterna Zentaris Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Rule

COSCIENS Biopharma

26/01/2022 22:10

Jan 26 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS GRANTED 180-DAY EXTENSION BY NASDAQ TO
REGAIN
COMPLIANCE WITH MINIMUM BID PRICE RULE

Source text for Eikon:  ID:nGNX1xS0vl 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))